Premium
A STUDY OF CORTICOTROPH ADENOMAS IN CUSHING'S DISEASE: NO EVIDENCE OF INTERMEDIATE LOBE ORIGIN
Author(s) -
McNICOL ANNE M.,
TEASDALE G. M.,
BEASTALL G. H.
Publication year - 1986
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.1986.tb01668.x
Subject(s) - corticotropic cell , hyperprolactinaemia , cushing's disease , pars intermedia , adenoma , medicine , endocrinology , pituitary gland , pathology , lobe , biology , disease , prolactin , hormone
SUMMARY There is little evidence for a separate functional or anatomical intermediate lobe in the adult human pituitary gland. Nevertheless, Lamberts et al. (1982) proposed that a subgroup of corticotroph adenomas in Cushing's disease arise in that lobe and can be identified by the presence of argyrophil (? neural) fibres, and that these tumours are more often associated with corticotroph hyperplasia and hyperprolactinaemia than those arising in the anterior lobe. We have examined a series of corticotroph adenomas from patients with Cushing's disease for evidence of argyrophil fibres, and have correlated this with tumour site, corticotroph distribution in the para‐adenomatous gland, serum PRL levels and PRL immunoreactive cells in the tumour. Argyrophil fibres were identified not only in tumours adjacent to the posterior lobe, but also in tumours situated deep in the anterior lobe. There was no correlation between the presence of fibres or the site of the tumour and corticotroph hyperplasia. Whilst the two patients with the highest serum PRL levels did have argyrophil fibres they also had a subpopulation of PRL immunoreactive cells in the tumour. On the basis of these results, we propose that the ‘intermediate lobe’ hypothesis as outlined above should not be accepted.